Post by
palinc2000 on Nov 16, 2021 10:27am
Soleus
Mission"
The Firm seeks to generate superior risk-adjusted returns through idiosyncratic, catalyst-driven investing with a focus on complex and niche opportunities in the Public and Private space.
I find it interesting that they have increased theur hokdings in THTX during the last Quarter,,....Obviously they are not risk adverse but I am trying to see their record in early stage biotechs and see how successful they have been in being ahead of the curve but did not find much .......,,,Anyone???